Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 4/20 | 0.44 |
| ▸ | CA3 | P07451 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP9 | P14780 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | MMP13 | P45452 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1234763 | 1.00 | GBA1 (0.44) | GBA1CA3CA5ACA5BCA2 | |
| SCHEMBL1234893 | 1.00 | GBA1 (0.44) | GBA1CA3CA5ACA5BCA2 | |
| SCHEMBL8088030 | 0.86 | GBA1 (0.50) | GBA1CA3CA5ACA5BCA2 | |
| SCHEMBL8087339 | 0.84 | GBA1 (0.49) | GBA1CA3CA5ACA5BCA2 | |
| SCHEMBL10046572 | 0.79 | GBA1 (0.44) | GBA1 | |
| SCHEMBL1234198 | 0.77 | GBA1 (0.39) | GBA1CA2THRB | |
| SCHEMBL15625533 | 0.76 | GBA1 (0.43) | GBA1 | |
| SCHEMBL20746294 | 0.75 | GBA1 (0.38) | GBA1CA2CA1MMP1MMP2 | |
| SCHEMBL5386730 | 0.75 | GBA1 (0.37) | GBA1CA2CA1MMP1MMP2 | |
| SCHEMBL6029680 | 0.75 | GBA1 (0.37) | GBA1CA2CA1MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2287270-B1 | Compound containing a fluorinated amide group | DU PONT (US) | 2013-04-03 | — | — | EP | disclosed |
| US-8389657-B2 | Poly(meth)acrylamides and poly(meth)acrylates containing flourinated amide | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-03-05 | — | — | US | disclosed |
| US-20120264972-A1 | POLY(METH)ACRYLAMIDES AND POLY(METH)ACRYLATES CONTAINING FLUORINATED AMIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-10-18 | — | — | US | disclosed |
| EP-2054452-B1 | POLY(METH)ACRYLAMIDES AND POLY(METH)ACRYLATES CONTAINING FLUORINATED AMIDE | DU PONT (US) | 2012-09-19 | — | — | EP | disclosed |
| US-8178638-B2 | Poly(meth)acrylamides and poly(meth)acrylates containing fluorinated amide | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-05-15 | — | — | US | disclosed |
| EP-2287270-A2 | Composition containing fluorinated amide | E. I. du Pont de Nemours and Company (US) | 2011-02-23 | — | — | EP | disclosed |
| US-20100233419-A1 | POLY(METH)ACRYLAMIDES AND POLY(METH)ACRYLATES CONTAINING FLUORINATED AMIDE | E.I.DU PONT DE NEMOURS AND COMPANY (US) | 2010-09-16 | — | — | US | disclosed |
| US-7754838-B2 | Poly(meth)acrylamides and poly(meth)acrylates containing fluorinated amide | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-13 | — | — | US | disclosed |
| EP-2054452-A2 | POLY(METH)ACRYLAMIDES AND POLY(METH)ACRYLATES CONTAINING FLUORINATED AMIDE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008021153-A2 | POLY(METH)ACRYLAMIDES AND POLY(METH)ACRYLATES CONTAINING FLUORINATED AMIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-02-21 | — | — | WO | disclosed |
| US-20080039605-A1 | Poly(meth)acrylamides and poly(meth)acrylates containing fluorinated amide | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233419-A1 | POLY(METH)ACRYLAMIDES AND POLY(METH)ACRYLATES CONTAINING FLUORINATED AMIDE | FGB, AFF1, AFF4 | GBA1 3637/4885CA3 1274/4885CA5A 2689/4885 |
| US-20120264972-A1 | POLY(METH)ACRYLAMIDES AND POLY(METH)ACRYLATES CONTAINING FLUORINATED AMIDE | AFF1, AFF2, AFF4 | GBA1 3227/4885CA3 1503/4885CA5A 2615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.